184 related articles for article (PubMed ID: 11019424)
1. [Diovan effectiveness in combined treatment of severe arterial hypertension].
Bichan NA; Maslov AP
Ter Arkh; 2000; 72(8):34-6. PubMed ID: 11019424
[TBL] [Abstract][Full Text] [Related]
2. [Diovan efficacy and tolerance in mild and moderate hypertension].
Zakirova AN; Zakirova NE
Ter Arkh; 1999; 71(4):41-4. PubMed ID: 10358862
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and tolerance of ACE inhibitor invoril and angiotensin I At-receptor blocker diovan in patients with stages I-II of arterial hypertension].
Nesterov IuI; Tepliakov AT; Spoeva VI
Klin Med (Mosk); 2002; 80(8):46-9. PubMed ID: 12360620
[TBL] [Abstract][Full Text] [Related]
4. [The hypotensive effect and tolerance of valsartan (Diovan) in hypertension in a general clinical practice].
Ivleva AIa; Sokolova MA; Moiseev VS
Ter Arkh; 1999; 71(2):67-70. PubMed ID: 10222559
[TBL] [Abstract][Full Text] [Related]
5. [Efficiency of diovan (valsartane) in arterial hypertension patients].
Novokrestova SV; Salamatina LV; Buganov AA; Umanskaia EL; Shesterikova NV; Mamedova SI
Med Tr Prom Ekol; 2003; (4):28-32. PubMed ID: 12872461
[TBL] [Abstract][Full Text] [Related]
6. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
Rosolová H; Cech J; Sefrna F
Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546
[TBL] [Abstract][Full Text] [Related]
8. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
9. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
Ferri C; Croce G; Desideri G
Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
[TBL] [Abstract][Full Text] [Related]
10. Valsartan. Just a second-line antihypertensive drug.
Can Fam Physician; 1999 Nov; 45():2626-8, 2630-3. PubMed ID: 10587770
[TBL] [Abstract][Full Text] [Related]
11. [New prospects in the treatment of arterial hypertension. Antagonist of angiotensin II valsartan (diovan)].
Ivleva AIa
Ter Arkh; 1998; 70(9):85-8. PubMed ID: 9821238
[No Abstract] [Full Text] [Related]
12. Effects of valsartan with or without benazepril on blood pressure, angiotensin II, and endoxin in patients with essential hypertension.
Ke YS; Tao YY; Yang H; Yu GH
Acta Pharmacol Sin; 2003 Apr; 24(4):337-41. PubMed ID: 12676074
[TBL] [Abstract][Full Text] [Related]
13. [Arterial hypertension: problems of maintenance therapy].
Kozlovskiĭ IV
Ter Arkh; 2006; 78(4):50-3. PubMed ID: 16821422
[TBL] [Abstract][Full Text] [Related]
14. [Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives].
Weisser B; Vetter H; Mengden T
Dtsch Med Wochenschr; 2003 Mar; 128(11):541-4. PubMed ID: 12635025
[TBL] [Abstract][Full Text] [Related]
15. Fixed combination therapy of hypertension: focus on valsartan/hydrochlorothiazide combination (Diovan/HCT).
Chrysant SG
Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):335-43. PubMed ID: 15030262
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
18. Valsartan: new preparation. Just a second-line antihypertensive drug.
Prescrire Int; 1998 Oct; 7(37):144-5. PubMed ID: 10915419
[TBL] [Abstract][Full Text] [Related]
19. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
[TBL] [Abstract][Full Text] [Related]
20. A comparison of valsartan and perindopril in the treatment of essential hypertension in the malaysian population.
Bavanandan S; Morad Z; Ismail O; Chandran A; Thayaparan T; Singaraveloo M
Med J Malaysia; 2005 Jun; 60(2):158-62. PubMed ID: 16114156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
